Integrative Analysis of Lung Cancer Risk and Causes
Official title: Integrative Analysis of Lung Cancer Etiology and Risk
Funded at University of New Mexico Health Scis Ctr · NIH-11523876 · Data updated 2026-11-12
A large NIH project is exploring how tobacco use, behavior, biology, and screening practices influence lung cancer risk and outcomes to help prevent and detect it earlier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project start | August 1, 2017 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $498,872 |
| NIH project number | 3U19CA203654-10S1 |
| Project ID | NIH-11523876 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals at risk for lung cancer or with a history of smoking, and patients undergoing lung cancer screening.
✕Less likely to help
People without risk factors or not pursuing screening may see limited direct benefit.
What this research studies
This project looks at how factors like smoking, behavior, and biological markers contribute to lung cancer risk and the effectiveness of screening. It uses an integrated approach across prevention, early detection, and management to reduce lung cancer deaths. By studying diverse populations and real-world screening patterns, it aims to identify ways to lower the burden of this disease for patients and families.
Why it matters
Potential benefit: If successful, it could lead to better prevention strategies, improved screening guidelines, and earlier, more accurate detection of lung cancer, potentially saving lives.
How similar studies have gone: Previous efforts show that combining behavioral and biological data can improve understanding of cancer risk and screening outcomes, with ongoing improvements.
Where this research is happening
-
University of New Mexico Health Scis Ctr
Albuquerque, United States Active
Researchers
- Principal investigator: Amos, Christopher I. — University of New Mexico Health Scis Ctr
- Study coordinator: Amos, Christopher I.
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Integrative Analysis of Lung Cancer Risk and Its Causes
A large, multi-part study at the University of New Mexico is exploring why lung cancer happens and how to better prevent and detect it.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Proteomics-guided matching of lung cancer tumors to preclinical models
This grant aims to improve how we match a patient’s lung cancer tumor to the right preclinical models using protein data.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.